Delivery Order SPE2D020D0009-SPE2D325F0803

Award Date 10/23/24
Potential Completion Date 10/28/24
Potential Value $40K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order (SPE2D020D0009|SPE2D325F0869) from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency, to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The $369,567.80 firm-fixed-price contract is for the delivery of 4,566,196,941 units of the antibiotic drug vancomycin in 1 gram vials. The contract has an ultimate completion date of October 29, 2024 and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This federal contract award, with ID SPE2D020D0009|SPE2D325F0809, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4,566,184,648 units of the injectable medication Vancomycin 1 gm vials, with a ceiling value of $29,455.86. The contract is structured as a Firm Fixed Price Delivery Order and has an ultimate completion date of October...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The $77,398.92 award is for the delivery of 1 gram vials of vancomycin hydrochloride, a critical antibiotic used in the federal government's medical supply chain. This order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle...
This is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule contract, awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, a critical antibiotic medication. The award has a ceiling value of $204,603.28 and a period of performance ending on March 31, 2016. This contract does...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of vancomycin hydrochloride, a critical antibiotic medication, in 1 gram vial quantities. The contract has a ceiling value of $82,938.72 and a period of performance that ends on October 2, 2015. This contract award is part of the Pharmaceuticals and Drugs Federal Supply...
This is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle managed by the Department of Veterans Affairs. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a defense agency, to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The award is for the delivery of 1 gram vials of vancomycin hydrochloride, an antibiotic medication, with a ceiling value of...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical, a subordinate command of the Department of Defense, to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The contract is for the delivery of 1 gram vials of vancomycin hydrochloride, an injectable antibiotic, with a ceiling value of $271,291.92 and a period of performance ending on March 31, 2016. The contract was awarded on September 24, 2015 and does not carry a...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F0803
    Delivery Order

This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price delivery order with no set-aside designation. Fresenius Kabi, LLC is a significant supplier of injectable medications and medical solutions to the Department of Defense and Department of Veterans Affairs, holding a $2.24 million indefinite delivery contract with the VA National Acquisition Center for the cancer treatment drug bortezomib.

Generated 1/22/25, 9:26 AM